The SARS-CoV-2 (COVID-19) IgA ELISA is intended for the qualitative determination of IgA class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin) to support the diagnosis of COVID-19 disease and constitutes a supplement to direct pathogen detection.
Qualitative determination of IgA class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin).
Tests per Package: 96